KDM1A and non-small cell lung carcinoma: To determine whether sanguinarine is a cellular active LSD1 inhibitor, the methylation levels of LSD1 substrates H3K4 and H3K9 were evaluated in NSCLC cell lines H1299 and H1975 treated with sanguinarine.